Why the study?
Is flow-mediated dilation impaired in women with polycystic ovary syndrome compared to controls?
Is flow-mediated dilation impaired in women with polycystic ovary syndrome compared to controls?
Women with polycystic ovary syndrome have significantly impaired endothelial function as measured by flow-mediated dilation compared to controls, independent of age and BMI.
No takes yet. Share an insight, caveat, or question.
PCOS-related endothelial dysfunction warrants closer CVD risk monitoring in practice; confirms impairment as a consistent, BMI-independent feature.
Sprung et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: